Related Experiment Videos
Placebo as a treatment for depression
1Brown University School of Medicine, Providence, Rhode Island.
Summary
The placebo effect in depression treatment is significant, with response rates nearing 50% in some cases. Researchers propose using placebo as an initial treatment for selected depression patients, emphasizing informed consent.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- The placebo response rate in depression consistently ranges from 30% to 40%.
- Antidepressants show a clear advantage over placebo in severely depressed patients.
- For less severe depression or shorter episode durations, placebo response rates can reach 50%, often indistinguishable from antidepressant response.
Purpose of the Study:
- To explore the therapeutic potential of placebo in depression treatment.
- To re-evaluate the role of placebo response from a nuisance to a research and therapeutic opportunity.
Main Methods:
- Review of existing literature on placebo response rates in depression.
- Analysis of comparative effectiveness of antidepressants, psychotherapy, and placebo.
Main Results:
- No psychotherapy has consistently demonstrated an advantage over pill placebo in depression treatment.
- Psychotherapies share common features with placebo treatment, such as expectation, support, and hope mobilization.
- Placebo response rates are high, particularly in less severe depression and shorter episode durations.
Conclusions:
- The high placebo response rate suggests a significant non-specific therapeutic effect in depression.
- Initial treatment with placebo for four to six weeks is proposed for selected depressed patients.
- Informed consent is crucial, with patients understanding the placebo contains no active drug but can be helpful.